Glaukos (GKOS) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Glaukos Revenue Highlights


Latest Revenue (Y)

$314.71M

Latest Revenue (Q)

$96.67M

Main Segment (Y)

Glaucoma

Main Geography (Y)

United States

Glaukos Revenue by Period


Glaukos Revenue by Year

DateRevenueChange
2023-12-31$314.71M11.26%
2022-12-31$282.86M-3.79%
2021-12-31$294.01M30.70%
2020-12-31$224.96M-5.07%
2019-12-31$236.98M30.73%
2018-12-31$181.28M13.83%
2017-12-31$159.25M39.21%
2016-12-31$114.40M59.55%
2015-12-31$71.70M57.28%
2014-12-31$45.59M117.64%
2013-12-31$20.95M-

Glaukos generated $314.71M in revenue during NA 2023, up 11.26% compared to the previous quarter, and up 173.61% compared to the same period a year ago.

Glaukos Revenue by Quarter

DateRevenueChange
2024-09-30$96.67M1.02%
2024-06-30$95.69M11.76%
2024-03-31$85.62M3.95%
2023-12-31$82.36M5.53%
2023-09-30$78.05M-2.92%
2023-06-30$80.40M8.80%
2023-03-31$73.90M3.75%
2022-12-31$71.23M-0.06%
2022-09-30$71.27M-1.95%
2022-06-30$72.69M7.39%
2022-03-31$67.68M-7.59%
2021-12-31$73.24M-1.97%
2021-09-30$74.71M-4.33%
2021-06-30$78.09M14.90%
2021-03-31$67.97M-7.19%
2020-12-31$73.23M12.96%
2020-09-30$64.83M105.43%
2020-06-30$31.56M-42.97%
2020-03-31$55.34M-15.97%
2019-12-31$65.85M12.55%
2019-09-30$58.51M-0.16%
2019-06-30$58.60M8.47%
2019-03-31$54.03M-0.09%
2018-12-31$54.08M23.16%
2018-09-30$43.91M1.73%
2018-06-30$43.16M7.54%
2018-03-31$40.13M-3.64%
2017-12-31$41.65M3.06%
2017-09-30$40.41M-2.11%
2017-06-30$41.28M14.98%
2017-03-31$35.91M8.24%
2016-12-31$33.17M12.15%
2016-09-30$29.58M3.58%
2016-06-30$28.56M23.66%
2016-03-31$23.09M13.89%
2015-12-31$20.28M6.69%
2015-09-30$19.00M7.04%
2015-06-30$17.75M21.06%
2015-03-31$14.67M3.92%
2014-12-31$14.11M16.39%
2014-09-30$12.13M9.25%
2014-06-30$11.10M34.55%
2014-03-31$8.25M-

Glaukos generated $96.67M in revenue during Q3 2024, up 1.02% compared to the previous quarter, and up 120.24% compared to the same period a year ago.

Glaukos Revenue Breakdown


Glaukos Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 19
Glaucoma$230.97M
Corneal Health$6.02M

Glaukos's latest annual revenue breakdown by segment (product or service), as of Dec 19: Glaucoma (97.46%), and Corneal Health (2.54%).

Quarterly Revenue by Product

Product/ServiceDec 20Sep 20Jun 20Mar 20
Corneal Health$14.88M$12.90M$6.61M$11.20M
Glaucoma$58.36M$51.93M$24.95M$44.13M

Glaukos's latest quarterly revenue breakdown by segment (product or service), as of Dec 20: Glaucoma (79.68%), and Corneal Health (20.32%).

Glaukos Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
International$95.31M----
United States$219.40M$144.66M$170.80M--
Non Us---$45.64M$44.53M
U---$133.72M$192.46M

Glaukos's latest annual revenue breakdown by geography, as of Dec 23: United States (69.71%), and International (30.29%).

Quarterly Revenue by Country

CountrySep 24Jun 24Mar 24Dec 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
UNITED STATES$70.02M-------------------
Non-US$26.65M-------------------
United States-$66.82M$57.69M$144.69M$39.60M$35.11M$35.35M$37.21M$38.20M$33.90M$41.21M---------
International-$28.87M$27.93M-----------------
Non Us-----------$15.10M$16.41M$13.81M$16.30M$14.23M$7.39M$13.95M$13.29M$10.92M
U-----------$43.38M$46.31M$39.89M$56.93M$50.60M$24.17M$41.38M$52.56M$47.59M

Glaukos's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (72.43%), and Non-US (27.57%).

Glaukos Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
BRKRBruker$2.96B$800.70M
ITGRInteger$1.60B$746.27M
CNMDCONMED$1.24B$316.70M
LIVNLivaNova$1.15B$318.11M
NVRONevro$425.17M$101.90M
GKOSGlaukos$314.71M$96.67M
FNAParagon 28$216.39M$61.02M
KIDSOrthoPediatrics$148.73M$52.80M
SRDXSurmodics$132.58M$30.34M
SGHTSight Sciences$81.06M$20.16M
IRMDIRadimed$65.56M$18.33M
OFIXOrthofix Medical$100.00K$198.62M

GKOS Revenue FAQ


Glaukos's yearly revenue for 2023 was $314.71M, representing an increase of 11.26% compared to 2022. The company's yearly revenue for 2022 was $282.86M, representing a decrease of -3.79% compared to 2021. GKOS's yearly revenue for 2021 was $294.01M, representing an increase of 30.70% compared to 2020.

Glaukos's quarterly revenue for Q3 2024 was $96.67M, a 1.02% increase from the previous quarter (Q2 2024), and a 23.86% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $95.69M, a 11.76% increase from the previous quarter (Q1 2024), and a 19.02% increase year-over-year (Q2 2023). GKOS's quarterly revenue for Q1 2024 was $85.62M, a 3.95% increase from the previous quarter (Q4 2023), and a 15.86% increase year-over-year (Q1 2023).

Glaukos's revenue growth rate for the last 3 years (2021-2023) was 7.04%, and for the last 5 years (2019-2023) was 32.80%.

Glaukos's revenue streams in c 19 are Glaucoma, and Corneal Health. Glaucoma generated $230.97M in revenue, accounting 97.46% of the company's total revenue Corneal Health generated $6.02M in revenue, accounting 2.54% of the company's total revenue

For the fiscal year ending Dec 19, the largest source of revenue of Glaukos was Glaucoma. This segment made a revenue of $230.97M, representing 97.46% of the company's total revenue.